Nvidia once rattled IonQ stock. Now it plans to install IonQ tech
π IonQ's Superion 256 will be the first on-premise quantum processor installed at Nvidia's Accelerated Quantum Research Center (NVAQC) in 2027.
π The system connects directly to an Nvidia GB200 NVL72 via NVQLink technology for hybrid quantum-classical computing.
π» IonQ developed a real-time error-correction decoder running on standard CPUs, simulating up to 408 logical qubits with only 0.02% added execution time.
π Second-quarter revenue reached $80.1 million, representing a 287% year-over-year increase driven by rapid expansion.
π° IonQ raised its 2026 revenue guidance to $450-$460 million following the closure of the SkyWater acquisition.
π¦ The company holds approximately $2.0 billion in cash, cash equivalents, and investments on a pro forma basis.
π¦ First customer deliveries for the Superion 256 system are expected to begin in 2027 after orders were accepted in September.
π― IonQ targets commercially manufacturable fault-tolerant quantum systems by 2028 as its next major milestone.
π€ NVAQC integrates multiple quantum hardware partners including Quantinuum, Quantum Machines, and QuEra alongside IonQ.
- IonQ secured a landmark partnership with Nvidia to install its Superion 256 processor at the company's new research center, validating its technology for hybrid computing environments.
- The company demonstrated a breakthrough in error-correction by developing a decoder that runs on standard CPUs, achieving simulated benchmarks of 408 logical qubits with minimal latency overhead.
- IonQ reported robust financial growth with second-quarter revenue surging 287% year-over-year to $80.1 million, reflecting strong market demand for its quantum solutions.
- The company successfully raised its full-year 2026 revenue guidance to $450-$460 million after integrating the SkyWater acquisition, signaling confidence in future growth.
- IonQ maintains a strong balance sheet with approximately $2.0 billion in cash and investments, providing ample liquidity for R&D and commercial scaling efforts.